1,080 material Form 8-K filings that 839 companies we cover made with the SEC in May 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Integra LifeSciences' board approved the transition of Dr. Stuart M. Essig from Executive Chairman to non-executive Chairman, effective July 1, 2025, and the filing says the change does not result from any disagreement with the company or board. At the May 9, 2025 annual meeting, stockholders elected all eight director nominees, approved a 2,200,000-share increase to the equity incentive plan, and ratified PricewaterhouseCoopers LLP as auditor for 2025.
Board approved Dr. Essig's move from Executive Chairman to non-executive Chairman, effective July 1, 2025.
The filing states the transition is not the result of any disagreement with the company or board on operations, policies or practices.
Stockholders approved Amendment No. 2 to the equity incentive plan, adding 2,200,000 shares: 69,088,553 for and 2,388,890 against.
All eight director nominees were elected; PricewaterhouseCoopers LLP was ratified for fiscal 2025 with 72,960,045 votes for.
Selective Insurance Group said Brenda M. Hall, Executive Vice President and Chief Operating Officer of Standard Lines, will retire effective January 5, 2026, and that her retirement is not the result of any disagreement with the company. The company will search for a successor, and the filing reports no financial results or guidance changes.
Brenda M. Hall, EVP and COO, Standard Lines, notified the company of her retirement on May 9, 2025
Retirement effective January 5, 2026; the company will undertake a process to identify a successor
Hall joined Selective in 2001 and has held her current position since 2021
Filing states the retirement is not the result of any disagreement with the company
Meritage Homes disclosed that Executive Vice President and Chief Operating Officer Clint Szubinski notified the company on May 7, 2025 that he is terminating his employment for personal reasons. His anticipated final day is May 16, 2025, and the filing does not name a successor or describe the reasons further.
Clint Szubinski, EVP and Chief Operating Officer, gave notice on May 7, 2025
Anticipated final date of employment is May 16, 2025
Departure is stated to be for personal reasons; no successor is named in the filing
Neogen said director James P. Tobin will retire from its Board effective May 31, 2025, and that Andrea Wainer will join the Board effective June 1, 2025. The filing describes no financial results or guidance, so the change is a board composition update rather than a change in reported performance.
James P. Tobin, a director since 2016, retires effective May 31, 2025 and currently chairs the Governance and Sustainability Committee.
James C. Borel, Board Chair, will serve as interim chair of the Governance and Sustainability Committee until a successor is appointed.
Andrea Wainer joins the Board as a Class II director effective June 1, 2025, and will serve on the Governance and Sustainability and Science, Technology, and Innovation Committees.
Ms. Wainer previously served as Executive Vice President, Rapid and Molecular Diagnostics at Abbott Laboratories.
DexCom promoted Jacob S. Leach, its chief operating officer, to president and chief operating officer effective immediately, as of May 9, 2025. Chief Executive Officer Kevin Sayer remains CEO and Chairman, and Leach now reports to him. The filing does not describe a change to financial results or guidance.
Jacob S. Leach promoted to President and COO effective May 9, 2025; he reports to CEO Kevin Sayer
Annual base salary raised to $800,000, with a target annual cash bonus equal to 100% of base salary
In the president role, Leach also oversees corporate development and strategy, per the press release
Ford said Kyle Crockett, currently Vice President, Controller and Chief Accounting Officer at Carrier Global, will become Ford's Chief Accounting Officer after the company files its second-quarter Form 10-Q, and he will report to CFO Sherry House until then. Ford also disclosed his pay package and reported May 8 annual meeting results, including rejection of a shareholder proposal on supply chain emissions and net zero goals.
Crockett starts as Vice President, Accounting, and is expected to join Ford on May 19, succeeding Mark Kosman
Pay includes a $575,000 base salary, a 75% bonus target and a $600,000 annual stock award target, plus a $3.95 million sign-on bonus
At the May 8 annual meeting, shareholders approved the say-on-pay vote and the tax benefit preservation plan, while a proposal on supply chain emissions and net zero goals was rejected
IES Holdings appointed Kelly C. Janzen as a director effective May 12, 2025, and placed her on the Audit Committee. Her background is in finance and accounting, including recent roles as CFO of Vestis Corporation and CFO of BlueLinx Corporation.
Janzen was elected to the Board on May 12, 2025, and joined the Audit Committee the same day.
She has served as Executive Vice President and CFO of Vestis Corporation since February 2025.
Previously she was SVP, CFO and Treasurer of BlueLinx Corporation from April 2020 to August 2023.
The filing reports no financial results; it covers a board appointment only.
Atmus Filtration Technologies appointed Laura Heltebran as Senior Vice President, Chief Legal Officer and Corporate Secretary, effective May 13, 2025, reporting to CEO Steph Disher. She previously served as Executive Vice President and Chief Legal Officer at Wheels Up. The filing sets out her pay package, which matters to shareholders as a compensation commitment for a senior executive.
Appointment approved by the Board on May 8, 2025, effective May 13, 2025
Base salary of $500,000 with a target bonus of 65% of base salary
Target annual long-term equity incentive award of $700,000, plus a one-time target award of $500,000
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.